Dan Zhong
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 3
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 4
- Peroxisome Proliferator-Activated Receptors 3
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 13
-
- Dendrimers and Hyperbranched Polymers 5
-
- Cholesterol and Lipid Metabolism 4
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Dan Zhong
45 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 563
- Biomaterials 197
- Molecular Biology 775
- Biomedical Engineering 282
- Immunology 130
Countries citing papers authored by Dan Zhong
This map shows the geographic impact of Dan Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Zhong more than expected).
Fields of papers citing papers by Dan Zhong
This network shows the impact of papers produced by Dan Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Zhong. The network helps show where Dan Zhong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dan Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 33 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 82 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 35 | |
| 14 | 2019 | 33 | |
| 15 | 2014 | 60 | |
| 16 | 2014 | 8 | |
| 17 | 2013 | 44 | |
| 18 | 2012 | 7 | |
| 19 | 2011 | 28 | |
| 20 | Comparison of Effects of Radix Astragali and Triperygium Glucosides on Glomerular Mesangial Cells Proliferation and Interleukin-6 Secretion | 2005 | 2 |
About Dan Zhong
Dan Zhong is a scholar working on Cancer Research, Polymers and Plastics and Biotechnology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (13 papers), RNA Interference and Gene Delivery (11 papers), Dendrimers and Hyperbranched Polymers (5 papers), MicroRNA in disease regulation (4 papers), Cholesterol and Lipid Metabolism (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Cancer Research (563 citations), Biomaterials (197 citations) and Molecular Biology (775 citations). Dan Zhong has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Fengtian He, Zhongwei Gu, Kui Luo, Qiyong Gong, Gang Huang, Xianghui Xu, Yijun Zeng, Zhizhen Xu, Yunkun Li and Gengze Wu. Their work appears in journals such as Advanced Materials, Circulation and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.